Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 2 (2017) OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE Abstract  similar documents
E. B. Babanskaya, L. V. Menshikova
"... Aim. To analyze the factors of medical choice in the prescription of medicinal drug (MD ..."
 
Vol 1, No 1 (2005) MENOPAUSE AND CARDIOVASCULAR RISK Abstract  similar documents
D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva
"... A role of menopause as a cardiovascular risk factor is reviewed. Menopause influence ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... among the cardiovascular diseases in the economically developed and developing countries of the world ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... among the cardiovascular diseases in the economically developed and developing countries of the world ..."
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
"... concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases ..."
 
Vol 9, No 4 (2013) VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..."
 
Vol 15, No 5 (2019) Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them Abstract  similar documents
N. V. Pyrikova, O. N. Antropova, I. V. Osipova
"... of medicines. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is one of the main methods of treating ..."
 
Vol 15, No 5 (2019) Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) Abstract  similar documents
E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... ”). The incidence of cardiovascular diseases (CVD), non-CVD comorbidities, drug therapy and outcomes were analyzed ..."
 
Vol 1, No 1 (2005) DRUGS AND SMOKING Abstract  similar documents
J. V. Lukina
"... the metabolism of drugs. The number of researches showed decrease in efficacy of some cardiovascular drugs ..."
 
Vol 14, No 6 (2018) Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov
"... Aim. To evaluate the structure of combined cardiovascular diseases, drug treatment and observation ..."
 
Vol 15, No 4 (2019) Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... ), worth special noticing in the classes of sartans and thiazide diuretics, since both drugs have a long ..."
 
Vol 3, No 4 (2007) PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY Abstract  similar documents
B. A. Tatarskii
"... used to terminate of atrial fibrillation are given. The choice of antiarrhythmic drug is considerate ..."
 
Vol 14, No 5 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness Abstract  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
"... Aim. We aimed to compare effectiveness of new  class III antiarrhythmic drug  Refralon with direct ..."
 
Vol 14, No 6 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety Abstract  PDF (Eng)  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
"... Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current ..."
 
Vol 16, No 2 (2020) The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease Abstract  similar documents
G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov
"... ) and cardiovascular events (CVE) in the first year after PCI (secondary endpoint) in patients with stable coronary ..."
 
Vol 3, No 3 (2007) STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? Abstract  similar documents
R. G. Oganov, G. V. Pogosova
"... Results of current studies devoted to relationship between stress and cardiovascular morbidity ..."
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
"... patients of different ages in acute pharmacological test (APT). Material and methods. 119 patients ..."
 
Vol 6, No 4 (2010) HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE Abstract  similar documents
G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov
"... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..."
 
Vol 9, No 1 (2013) EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS Abstract  similar documents
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov
"... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... Guidelines are discussed. Problem of statin choice and problem of equivalence of generic drugs to original ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
"... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..."
 
Vol 2, No 4 (2006) QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? Abstract  similar documents
V. V. Iakusevich
"... Drug quality in modern market is discussed. There is an increase of a number of drugs that don ..."
 
Vol 14, No 1 (2018) STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) Abstract  similar documents
S. V. Povetkin, Ju. V. Luneva
"... Aim. To study the therapeutic efficacy and safety of generic drug of ivabradine in comparison ..."
 
Vol 7, No 6 (2011) COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
 
Vol 8, No 2 (2012) THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev
"... Aim. To compare two therapies based on the use of original or generic drugs in patients ..."
 
Vol 14, No 6 (2018) Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment Abstract  PDF (Eng)  similar documents
G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov
"... moxonidine versus reference drug. Material and methods. Objects of the research were film-coated tablets ..."
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... (Plavix) and its generic (Egitromb) in patients of high cardiovascular risk. Material and methods. Thirty ..."
 
Vol 11, No 5 (2015) Practical aspects of apixaban use in clinical practice: continuing the theme Abstract  similar documents
S. N. Bel'diev
"... and/or P-glycoprotein (P-gp) inhibitors. Analysis of clinical and pharmacological studies suggests ..."
 
Vol 14, No 4 (2018) Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment Abstract  similar documents
Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova
"... .), strategy and tactics of AF treatment in patients with STEMI, the indications for its pharmacological ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... Aim. To evaluate in a prospective 10-year follow-up study cardiovascular mortality rate ..."
 
Vol 16, No 4 (2020) Epicardial Adipose Tissue as a New Target of Therapeutic Interventions Abstract  similar documents
M. A. Druzhilov, T. Y. Kuznetsova
"... and severity of supraventricular arrhythmias. There is also a lot of evidence of the influence of both non-drug ..."
 
Vol 16, No 4 (2020) Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues Abstract  similar documents
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova
"... , considering the potential of these drugs in reducing cardiovascular morbidity and mortality in patients ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... with cardiovascular diseases are presented. The main practical ways to reduce the possible gastrointestinal ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..."
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
 
Vol 9, No 4 (2013) NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Abstract  similar documents
A. V. Rudenko, B. A. Rudenko
"... effects of both its ATC class  and drugs of previous generations. Its high antihypertensive  activity ..."
 
Vol 11, No 6 (2015) Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) Abstract  similar documents
O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko
"... Aim. To study the frequency and characteristics of alcohol use in outpatients with cardiovascular ..."
 
Vol 5, No 1 (2009) SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
"... – arterial hypertension (HT) and hypercholesterolemia (HH) in patients with high risk of cardiovascular ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... to provide high level of compliance in patients with cardiovascular diseases. ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..."
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..."
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..."
 
Vol 1, No 3 (2005) RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS Abstract  similar documents
D. A. Anichkov, N. A. Shostak
"... The cardiovascular risk factors in patients with rheumatoid arthritis (RA) are reviewed ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..."
 
Vol 14, No 3 (2018) COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU Abstract  similar documents
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca
"... questions on the pharmacoepidemiological aspects of prescribing antihypertensive drugs. Total number ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... The problem of antiplatelet drug choice in patients with atrial fibrillation is discussed. Authors ..."
 
Vol 12, No 1 (2016) A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register Abstract  similar documents
A. V. Zakharova, S. N. Tolpygina, V. P. Voronina, S. Yu. Martsevich
"... Aim. To study the efficacy and safety of generic orlistat in comparison with the original drug ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... (AH) 1-2 stage with increased risk of cardiovascular events. Material and methods. The study ..."
 
Vol 12, No 1 (2016) Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita Abstract  similar documents
S. N. Bel'diev
"... with these drugs: to 15 mg/day in patients with ClCr 50-79 ml/min and to 10 mg/day in patients with ClCr<50 ml/min. ..."
 
Vol 16, No 1 (2020) Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) Abstract  similar documents
N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva
"... considering a frequent administration of several drugs having different drug-drug interactions. Warfarin ..."
 
Vol 13, No 1 (2017) THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... of the cardiovascular system. Its connections to the increased incidence of myocardial infarction, stroke ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... Aim. To study the relationship of individual cardiovascular risk factors with arterial stiffness ..."
 
Vol 13, No 6 (2017) SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis Abstract  similar documents
O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina
"... of acute cardiovascular events during smoking include the activation of inflammation, platelet aggregation ..."
 
Vol 14, No 1 (2018) SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking Abstract  similar documents
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva
"... reduces the risk of developing stable and unstable angina, acute myocardial infarction, cardiovascular ..."
 
Vol 7, No 4 (2011) METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE Abstract  similar documents
M. S. Berezhnova
"... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... year worldwide, and cardiovascular complications happen in 500 000 - 900 000 patients. Aim ..."
 
Vol 6, No 5 (2010) PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE Abstract  similar documents
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva
"... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..."
 
Vol 11, No 1 (2015) VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT Abstract  PDF (Eng)  similar documents
R. G. Oganov
"... The problem of vascular comorbidity in patients with cardiovascular diseases, its effect ..."
 
Vol 9, No 1 (2013) CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE Abstract  similar documents
M. I. Shupina, O. Ju. Korennova, E. N. Loginova
"... . The total cardiovascular risk in patients of “Health school” and "Typical practice" groups after 12 months ..."
 
Vol 11, No 3 (2015) OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... acids are included into the treatment protocols for patients with cardiovascular diseases ..."
 
Vol 9, No 4 (2013) USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... of risk modification of cardiovascular complications in the perioperative period. Therefore, special ..."
 
Vol 11, No 2 (2015) LOW SODIUM DIET: PROS AND CONS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
 
Vol 10, No 1 (2014) ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES Abstract  similar documents
J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili
"... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..."
 
Vol 10, No 1 (2014) MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT Abstract  similar documents
E. I. Trisvetova
"... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..."
 
Vol 10, No 4 (2014) MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT Abstract  similar documents
A. Yu. Suvorov, S. Yu. Martsevich
"... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..."
 
Vol 8, No 3 (2012) MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... At present experimental and clinical data confirming efficacy of magnesium-containing drugs ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... cardiovascular diseases is one of the priorities of modern medicine. This therapy usually consists of several ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..."
 
Vol 5, No 1 (2009) CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC Abstract  similar documents
I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov
"... Aim. To assess the efficacy of specialized management of pregnant women with cardiovascular ..."
 
Vol 5, No 1 (2009) CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. A. Anichkov, A. A. Platonova
"... association between HRV indexes and cardiovascular risk factors and RA-related clinical characteristics ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... methods of the study and drug therapy of this pathology. Material and methods. The regional study (REKUR ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..."
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... pulse wave) with cardiovascular risk factors in women with rheumatoid arthritis (RA). Material ..."
 
Vol 5, No 3 (2009) CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov
"... Aim. To study clinical and economical rationales for cardiovascular risk evaluation at workplace ..."
 
Vol 5, No 3 (2009) ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
N. M. Nikitina, A. P. Rebrov
"... into account wide usage of non steroid antiinflammatory drugs calcium antagonists or angiotensin II receptor ..."
 
Vol 5, No 4 (2009) COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS Abstract  PDF (Eng)  similar documents
N. A. Karoli, A. P. Rebrov
"... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..."
 
Vol 4, No 4 (2008) CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS Abstract  similar documents
S. Y. Martsevich
"... Cardiovascular event risk reduction with medicines is discussed in the article. The role ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... of orotic acid and magnesium orotate on cardiovascular system as well as therapeutic implementation ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... . The evidence base of modern drugs for preventing the development of cardiovascular complications ..."
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
"... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..."
 
Vol 12, No 4 (2016) Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk Abstract  PDF (Eng)  similar documents
F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva
"... Aim. To study standardized all-cause mortality and cardiovascular mortality (or deaths due ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..."
 
Vol 11, No 5 (2015) Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need? Abstract  similar documents
A. N. Sumin
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... risk due to cardiovascular reasons. Favorable therapeutic effects of inhibiting RAS activity ..."
 
Vol 16, No 4 (2020) Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice Abstract  similar documents
D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan
"... to cardiovascular risk require an optimization of their pharmacotherapy in clinical practice. Aim. To study ..."
 
Vol 13, No 2 (2017) FALLING OF SENILE AGE PATIENT AS AN ADVERSE EVENT ASSOCIATED WITH THE USE OF MEDICINES: CASE REPORT Abstract  similar documents
E. S. Ilina, O. T. Bogova, S. V. Gorbatenkova, D. A. Sychev
"... . In this clinical case, the development of serious adverse reaction is significantly associated with adverse drug ..."
 
Vol 6, No 4 (2010) EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA Abstract  similar documents
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... are discussed. ASA interaction with other drugs and ASA pleiotropic effects are reviewed   ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... and tolerability of original and generic simvastatin. The drug effects on the blood levels of total cholesterol (TC ..."
 
Vol 5, No 6 (2009) ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina
"... OD). Conclusion. New generic amlodipine (Stamlo M) is an effective and safe antihypertensive drug ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... ) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application ..."
 
Vol 7, No 2 (2011) WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, I. V. Vashurina
"... The problem of generic drugs use in clinical practice and confirmation of their therapeutic ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... Aim. To compare efficacy of ramipril generic Hartil® (Egis) to original drug Tritace® in patients ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... Aim. To study the structure of risk factors and associated cardiovascular and concomitant non ..."
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
"... high and extremely high cardiovascular risk. The indication for the pharmacological treatment to reduce ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... as first-line drugs for stroke prevention, but in real medical practice antiplatelet drugs are often ..."
 
1 - 100 of 283 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)